9G2 — Singapore Institute of Advanced Medicine Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- SG$36.21m
- SG$82.31m
- SG$15.72m
Annual cashflow statement for Singapore Institute of Advanced Medicine Holdings, fiscal year end - June 30th, SGD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | R2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -12.4 | -18.1 | -37.4 | -27.1 | -23.9 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -1.11 | 3.96 | 16.3 | 5.33 | 3.86 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.47 | 5.11 | -4.3 | -0.829 | 5.6 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Cash from Operating Activities | -5.81 | -3.24 | -12.9 | -10.7 | -3.65 |
| Capital Expenditures | -4.11 | -14.4 | -0.534 | -0.148 | -0.489 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 7.83 | 13 | 0.278 | 0.281 | 0.432 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 3.72 | -1.45 | -0.256 | 0.133 | -0.057 |
| Financing Cash Flow Items | -2.7 | -3.74 | 0.428 | -1.73 | -1.7 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 7.84 | -0.099 | 7.92 | 10 | 15.8 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.75 | -4.79 | -5.27 | -0.497 | 12.1 |